北美哮喘药物市场预测至 2028 年 - COVID-19 影响和药物（快速缓解药物和长期控制药物）、给药途径（吸入、预充注射器/小瓶等）和分销渠道（在线）的区域分析药房、医院药房和零售药房）
No. of Pages: 141 | Report Code: BMIRE00025220 | Category: Life Sciences
No. of Pages: 141 | Report Code: BMIRE00025220 | Category: Life Sciences
市场的增长归因于哮喘患病率的上升和粗颗粒物暴露的增加。然而，未满足的医疗需求阻碍了市场增长。
根据 2018 年题为“低水平臭氧对呼吸系统和全身系统都有影响”的研究尽管进行了哮喘控制治疗，但室外臭氧水平低仍与患有哮喘的非裔美国青少年的哮喘的影响有关”，低水平的室外臭氧与患有难以治疗的哮喘的非裔美国儿童的呼吸异常和其他结果有关，即使他们正在使用哮喘药物，例如吸入器，减轻空气污染物的有害影响。
环境保护局 (EPA) 与北卡罗来纳大学教堂山分校的研究人员合作调查臭氧对北卡罗来纳州罗利患有中重度持续性哮喘的非裔美国儿童健康的影响。研究结果表明，低于国家环境空气质量标准 (NAAQS) 的臭氧水平与患有持续性哮喘的非裔美国儿童的肺部和其他变化有关。
美国肺脏协会流行病学和统计部门通过疾病预防控制中心的数据显示，美国波多黎各人的哮喘发病率最高，为 14%，其次是非裔美国人，为 11%，非拉丁裔白人为 8%。这证实了不同种族群体患哮喘的风险较高的事实，这推动了北美对哮喘药物的需求。
此外，研究人员发现，即使在臭氧水平较低且服用哮喘药物时，臭氧浓度的增加也与肺功能恶化有关。他们还发现，臭氧暴露与血液中脂肪化合物数量的增加有关，此前这种现象仅在成年人中观察到。研究表明，即使在低浓度下，臭氧也会影响弱势群体，而且其影响比单纯的呼吸系统后果更广泛。
越高族裔群体，尤其是波多黎各人和非裔美国人中存在的风险和脆弱性，推动了这些族裔群体密度较高地区对哮喘药物的需求。
< span>
北美哮喘药物市场按药物划分为快速缓解药物和长期控制药物。根据给药途径，市场分为吸入型、预装注射器/小瓶等。 根据分销渠道，北美哮喘药物市场分为在线药房、医院药房和零售药房。按国家/地区划分，市场分为美国、加拿大和墨西哥。
阿斯利康；梯瓦制药工业有限公司；
勃林格殷格翰国际有限公司；葛兰素史克公司；默克公司有限公司；皇家飞利浦公司；赛诺菲；
辉瑞公司 (Arena Pharmaceutical GmbH)；诺华公司；和雅培是北美 哮喘药物市场的领先公司之一。
Strategic insights for North America Asthma Drugs involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 10,146.51 Million |
| Market Size by 2028 | US$ 13,978.13 Million |
| Global CAGR (2021 - 2028) | 4.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 药物治疗
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Asthma Drugs refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Asthma Drugs Market is valued at US$ 10,146.51 Million in 2021, it is projected to reach US$ 13,978.13 Million by 2028.
As per our report North America Asthma Drugs Market, the market size is valued at US$ 10,146.51 Million in 2021, projecting it to reach US$ 13,978.13 Million by 2028. This translates to a CAGR of approximately 4.7% during the forecast period.
The North America Asthma Drugs Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Asthma Drugs Market report:
The North America Asthma Drugs Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Asthma Drugs Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Asthma Drugs Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Asthma Drugs Market
